Wall Street firms are increasingly making their internal tech free and available to use and modify — but they're not worried about losing an edge.

In its upcoming report, Edwards Lifesciences (EW) is predicted by Wall Street analysts to post quarterly earnings of $0.55 per share, reflecting a decline of 14.1% compared to the same period last ...